Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia

标题
Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia
作者
关键词
MAPK signaling cascades, Cancer treatment, Mouse models, Point mutation, Cholesterol, Cytometry, Cell viability testing, Leukemia cells
出版物
PLoS One
Volume 12, Issue 7, Pages e0179558
出版商
Public Library of Science (PLoS)
发表日期
2017-07-19
DOI
10.1371/journal.pone.0179558

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search